The most commonly reported side effects of adalimumab, as well as other TNF-α inhibitors, include sepsis due to bacterial, fungal, and viral infections, opportunistic infections, pneumonias, pyelonephritis, septic arthritis, and tuberculosis [52]. The gene discussed is TNF; the disease is viral infectious disease.